INTRODUCTION AND OBJECTIVE:Oral methyltestosterone (MT) was approved for a testosterone replacement therapy (TRT) in males with a deficiency of endogenous testosterone. Due to its liver toxicity, t... Click to show full abstract
INTRODUCTION AND OBJECTIVE:Oral methyltestosterone (MT) was approved for a testosterone replacement therapy (TRT) in males with a deficiency of endogenous testosterone. Due to its liver toxicity, t...
               
Click one of the above tabs to view related content.